L&K Bio Completes Patent Barrier for Height-Expandable Cage

[Asia Economy Reporter Hyungsoo Park] L&K Biomed has acquired a fundamental patent related to height-expandable interbody fusion devices (cages).

On the 21st, L&K Biomed announced that it has expanded the scope of patent rights to prevent patent circumvention through modifications of the fundamental technology of height-expandable cages. Additionally, the company secured a patent for the lateral insertion method of height-expandable cages, expecting to strengthen its competitiveness in the height-expandable cage market.

An L&K Biomed official stated, "Interest in height-expandable cages is growing in the spinal implant field," and added, "It was difficult for competitors to enter the market due to patents held by global companies."

He continued, "L&K Biomed devised a structure that can avoid patents held by leading companies," emphasizing, "Based on this new structure, we developed 10 types of height-expandable cages."

Previously, in September last year, L&K Biomed received FDA approval for the posterior insertion type height-expandable cage (AccelFix-XT), lateral insertion type height-expandable cage (AccelFix-XL), and lateral insertion type height-expandable cage (Accelfix-XTP). The posterior insertion type height-expandable cage has achieved approximately 600 surgical cases in the U.S. market, gaining recognition for product performance and safety.

The official said, "With the patent acquisition, L&K Biomed has secured all conditions for market dominance of height-expandable cages, including quality competitiveness, product approval, and patent rights."

He added, "Having achieved both FDA registration and patent acquisition," and said, "While focusing on marketing to increase market share, we expect to conclude large-scale contracts."

This content was produced with the assistance of AI translation services.